Searchable abstracts of presentations at key conferences in endocrinology

ea0063p148 | Diabetes, Obesity and Metabolism 1 | ECE2019

Prevalence and risk factors of hepatic steatosis among patients with chronic hepatitis B

Ayari Myriam , Kchir Hella , Cherif Dhouha , Issaoui Dhilel , Maamouri Nadia

Introduction: Chronic hepatitis and NAFLD represent a global public health problem since they are two common cause of chronic liver disease. Hepatic steatosis (HS) is becoming highly prevalent worldwide and its association with hepatitis B, although controversial previously, is increasingly encountered and thought to be related to host factors.Aim and methods: The aim of this retrospective study is to determine the prevalence of HS in chronic hepatitis B...

ea0099ep939 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Screening and quantification of hepatic steatosis in obese patients using the controlled attenuation parameter (CAP)

Mohamed Nefzi Ahmed , Dhouha Cherif , Fatma Kahlaoui , Habiba Dabbebi , Haythem Yacoub , Hajer Hassine , Hela Kchir , Nadia Maamouri

Introduction: Liver steatosis currently represents a hepatic manifestation of metabolic syndrome. It occurs more frequently in patients with obesity, and liver biopsy remains the gold standard for the positive diagnosis of this condition. In recent decades, the positive diagnosis of hepatic steatosis has increasingly relied on non-invasive methods such as Controlled Attenuation Parameter (CAP). The objective of this study was to investigate the prevalence of hepatic steatosis ...